Quantcast

Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.

Research paper by Hanne F HF Harbo, Noriko N Isobe, Pål P Berg-Hansen, Steffan D SD Bos, Stacy J SJ Caillier, Marte W MW Gustavsen, Inger-Lise IL Mero, Elisabeth Gulowsen EG Celius, Stephen L SL Hauser, Jorge R JR Oksenberg, Pierre-Antoine PA Gourraud

Indexed on: 09 Oct '13Published on: 09 Oct '13Published in: Multiple sclerosis (Houndmills, Basingstoke, England)



Abstract

Many genetic risk variants are now well established in multiple sclerosis (MS), but the impact on clinical phenotypes is unclear.To investigate the impact of established MS genetic risk variants on MS phenotypes, in well-characterized MS cohorts.Norwegian MS patients (n = 639) and healthy controls (n = 530) were successfully genotyped for 61 established MS-associated single nucleotide polymorphisms (SNPs). Data including and excluding Major Histocompatibility Complex (MHC) markers were summed to a MS Genetic Burden (MSGB) score. Study replication was performed in a cohort of white American MS patients (n = 1997) and controls (n = 708).The total human leukocyte antigen (HLA) and the non-HLA MSGB scores were significantly higher in MS patients than in controls, in both cohorts (P < 10(-22)). MS patients, with and without cerebrospinal fluid (CSF) oligoclonal bands (OCBs), had a higher MSGB score than the controls; the OCB-positive patients had a slightly higher MSGB than the OCB-negative patients. An early age at symptom onset (AAO) also correlated with a higher MSGB score, in both cohorts.The MSGB score was associated with specific clinical MS characteristics, such as OCBs and AAO. This study underlines the need for well-characterized, large cohorts of MS patients, and the usefulness of summarizing multiple genetic risk factors of modest effect size in genotype-phenotype analyses.

More like this: